This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 1989 Jan 13;38(1):11-4.

Measles prevention: supplementary statement

Centers for Disease Control (CDC)

PMID: 2491907

Guideline

Measles prevention: supplementary statement

Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep. 1989.

. 1989 Jan 13;38(1):11-4.

Author

Centers for Disease Control (CDC)

PMID: 2491907

No abstract available

PubMed Disclaimer

Similar articles

Leads from the MMWR. Measles prevention: supplementary statement.
[No authors listed] [No authors listed] JAMA. 1989 Feb 10;261(6):827, 831. JAMA. 1989. PMID: 2913378 No abstract available.
Statement on recommended use of measles vaccine in Canada.
[No authors listed] [No authors listed] CMAJ. 1990 Aug 15;143(4):287-9. CMAJ. 1990. PMID: 2383849 Free PMC article. No abstract available.
ACIP releases supplementary report on measles prevention.
[No authors listed] [No authors listed] Am Fam Physician. 1989 Apr;39(4):379. Am Fam Physician. 1989. PMID: 2610194 No abstract available.
Worldwide measles prevention.
Orenstein WA, Markowitz LE, Atkinson WL, Hinman AR. Orenstein WA, et al. Isr J Med Sci. 1994 May-Jun;30(5-6):469-81. Isr J Med Sci. 1994. PMID: 8034506 Review.
Measles vaccination.
Allam MF. Allam MF. J Prev Med Hyg. 2009 Dec;50(4):201-5. J Prev Med Hyg. 2009. PMID: 20812514 Review. No abstract available.

See all similar articles

Cited by

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial.
Zaman K, Yunus M, Aziz AB, Feser J, Mooney J, Tang Y, Ellison DW, Thaisomboonsuk B, Zhang L, Neuzil KM, Marfin AA, Letson GW. Zaman K, et al. Vaccine X. 2022 Feb 5;10:100143. doi: 10.1016/j.jvacx.2022.100143. eCollection 2022 Apr. Vaccine X. 2022. PMID: 35243320 Free PMC article.
The Continued Risk of Measles Outbreaks in the United States Resulting From Suboptimal Vaccination Coverage.
Bednarczyk RA, Sundaram ME. Bednarczyk RA, et al. Public Health Rep. 2025 Jan 3:333549241306608. doi: 10.1177/00333549241306608. Online ahead of print. Public Health Rep. 2025. PMID: 39749889 Free PMC article. No abstract available.
Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine.
Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Zhang C, Ngo L, Rubin S. Fiebelkorn AP, et al. Open Forum Infect Dis. 2014 Oct 18;1(3):ofu094. doi: 10.1093/ofid/ofu094. eCollection 2014 Dec. Open Forum Infect Dis. 2014. PMID: 25734162 Free PMC article.
The need for a standard national immunization record.
Yarboro TL, Harry B, Hough E, Moyers K, Muscarella T. Yarboro TL, et al. J Natl Med Assoc. 1991 May;83(5):409-14. J Natl Med Assoc. 1991. PMID: 1875420 Free PMC article.
The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.
Hyle EP, Fields NF, Fiebelkorn AP, Walker AT, Gastañaduy P, Rao SR, Ryan ET, LaRocque RC, Walensky RP. Hyle EP, et al. Clin Infect Dis. 2019 Jul 2;69(2):306-315. doi: 10.1093/cid/ciy861. Clin Infect Dis. 2019. PMID: 30312374 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information